FINAL-- DNA Repair and Cancer therapies #14 Flashcards
DNA Damage Responce (DDR)
Maintenance of genome integrity is essential for cell survival and the faithful transfer of genetic information. Eukaryotic cells evolved a DNA damage response (DDR) to sense, evaluate, and repair chromosome and DNA lesions or to direct cells for destruction when the harm is irreparable.
Detection of DNA damage and activation of DNA repair
If a mutation is detected, the cell cycle will arrest and the mutation will be repaired before the cell re-enters the cell cycle, or the cell will enter apoptosis.
- p53 controls the process and Mdm2 negatively regulates p53
p53 pathway
In a normal cell, p53 is inactivated by its negative regulator, mdm2. Upon DNA damage or other stresses, various pathways will lead to the dissociation of the p53 and mdm2 complex. Once activated, p53 will induce a cell cycle arrest to allow either repair and survival of the cell or apoptosis to discard the damaged cell. How p53 makes this choice is currently unknown
DNA repair pathways
cellular responses that are associated with the restoration of the normal pair sequence and structure of damaged DNA
- 6 primary DNA repair pathways
- Series of biochemical events: sensing, excision, and restoration of the normal DNA sequence.
Major Proteins involved with DNA repair include:
- Sensory (DNA binding) proteins
- Enzymes that remove damaged bases
- Enzymes that restore the normal DNA sequence
- Regulatory enzymes
DNA repair pathways and cancer
- Cancer cells are often deficient in a normal DNA repair function and this
deficiency allows the tumor to develop genomic instability.
-
With defective DNA repair, the tumor can:
Break and reform chromosomes
Generate new oncogenic fusion genes
Disrupt tumor suppressor genes
Amplify drug-resistance genes
progress to a more malignant state.
Cancer Therapies
- Surgery
- Radiation
- Hormonal therapy
- Chemotherapy
- Targeted therapy
- Immunotherapy
Targeted therapy
Inhibits proteins that are mutated or overexpressed and helps the cancer to grow - this makes the therapy more cancer-specific
Immunotherapy
Use of medicines to stimulate a patient’s immune system to recognize and destroy cancer cells more effectively
Cytostatic drug
a drug that stops cell growth
Cytotoxic drug
a drug that kills cells
Chemosensitizer
inhibits normal DNA repair processes (limits toxicity)
What happens if a tumor is defective in one pathway?
It may be hyper-dependent on a second pathway for its survival. Accordingly, a drug, such as a PARP inhibitor, that targets the second pathway may be selectively toxic to these tumors.